 |
|
|
| |
INSTI-based initial ART in the HIV Outpatient Study [Integrase s Non-Integrase Viral Suppression/Duration of ART]
|
| |
| |
Reported by Jules Levin
CROI 2018 March 4-7 Boston MA
S Mayer1, N Rayeed2, R Hart2, RM Novak1, B Yangco3, FJ Palella4, B Young5, and K Buchacz6 for the HIV Outpatient Study (HOPS)
1 University of Illinois at Chicago, Chicago, IL, US; 2Cerner Corporation, Kansas City, MO, US; 3Infectious Disease Research Institute, Tampa, FL, US; 4Northwestern University Feinberg School of Medicine, Chicago, IL, US; 5APEX Family Medicine, Denver, CO, US; 6U.S. Centers for Disease Control and Prevention, Atlanta, GA, US
|
| |
|
|
|
|
|
